StemCell Institute
TSE:7096

Watchlist Manager
StemCell Institute Logo
StemCell Institute
TSE:7096
Watchlist
Price: 866 JPY 1.29% Market Closed
Market Cap: 8.9B JPY

Wall Street
Price Targets

Price Targets Summary
StemCell Institute

There are no price targets for StemCell Institute.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
StemCell Institute Competitors:
Price Targets
286A
EUCALIA Inc
54% Upside
2522
Jiangxi Rimag Group Co Ltd
432% Upside
PINC
Premier Inc
42% Upside
WELL
WELL Health Technologies Corp
88% Upside
FRE
Fresenius SE & Co KGaA
12% Upside
QC7
Q & M Dental Group (Singapore) Ltd
6% Downside
OPTIMAX
Optimax Holdings Bhd
31% Upside

Revenue
Forecast

Revenue Estimate
StemCell Institute

For the last 6 years the compound annual growth rate for StemCell Institute's revenue is 15%. The projected CAGR for the next 3 years is 17%.

15%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
StemCell Institute

Operating Income forecast
is not available for
StemCell Institute

Net Income
Forecast

Net Income Estimate
StemCell Institute

For the last 6 years the compound annual growth rate for StemCell Institute's net income is 18%. The projected CAGR for the next 3 years is 10%.

18%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is StemCell Institute's stock price target?
Not Available

StemCell Institute doesn't have any price targets made by Wall Street professionals.

What is StemCell Institute's Revenue forecast?
Projected CAGR
17%

For the last 6 years the compound annual growth rate for StemCell Institute's revenue is 15%. The projected CAGR for the next 3 years is 17%.

What is StemCell Institute's Net Income forecast?
Projected CAGR
10%

For the last 6 years the compound annual growth rate for StemCell Institute's net income is 18%. The projected CAGR for the next 3 years is 10%.

Back to Top